Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Souers

Showing results (221-230 of 248) with videos related to

Pageof 25
Sort By:
Journal of Medicinal Chemistry|March 4, 2011
Quinazoline sulfonamides as dual binders of the proteins B-cell lymphoma 2 and B-cell lymphoma extra long with potent proapoptotic cell-based activityBrad E Sleebs, Peter E Czabotar, Wayne J Fairbrother, et al.
Leukemia|December 13, 2019
A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignanciesDarren C Phillips, Sha Jin, Gareth P Gregory, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonistsAnil Vasudevan, Andrew J Souers, Jennifer C Freeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2017
Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 ExpressionTimothy L Lochmann, Konstantinos V Floros, Mitra Naseri, et al.
Nature Communications|November 21, 2024
Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in gliomaElizabeth G Fernandez, Wilson X Mai, Kai Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2018
Increased Synthesis of MCL-1 Protein Underlies Initial Survival of <i>EGFR</i>-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug TargetKyung-A Song, Yasuyuki Hosono, Crystal Turner, et al.
ACS Medicinal Chemistry Letters|July 16, 2021
Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 InhibitorsYunsong Tong, Alan S Florjancic, Rick F Clark, et al.
Archives of Pathology & Laboratory Medicine|December 2, 2023
Recommendations for Performance Evaluation of Machine Learning in Pathology: A Concept Paper From the College of American PathologistsMatthew G Hanna, Niels H Olson, Mark Zarella, et al.
Bioorganic & Medicinal Chemistry Letters|January 20, 2007
An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonistsRajesh R Iyengar, John K Lynch, Mathew M Mulhern, et al.
Bioorganic & Medicinal Chemistry Letters|August 9, 2005
Identification of ortho-amino benzamides and nicotinamides as MCHr1 antagonistsAnil Vasudevan, Matthew J LaMarche, Christopher Blackburn, et al.
Pageof 25

Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
Journal of Medicinal Chemistry|March 4, 2011
Quinazoline sulfonamides as dual binders of the proteins B-cell lymphoma 2 and B-cell lymphoma extra long with potent proapoptotic cell-based activityBrad E Sleebs, Peter E Czabotar, Wayne J Fairbrother, et al.
Leukemia|December 13, 2019
A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignanciesDarren C Phillips, Sha Jin, Gareth P Gregory, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonistsAnil Vasudevan, Andrew J Souers, Jennifer C Freeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2017
Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 ExpressionTimothy L Lochmann, Konstantinos V Floros, Mitra Naseri, et al.
Nature Communications|November 21, 2024
Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in gliomaElizabeth G Fernandez, Wilson X Mai, Kai Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2018
Increased Synthesis of MCL-1 Protein Underlies Initial Survival of <i>EGFR</i>-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug TargetKyung-A Song, Yasuyuki Hosono, Crystal Turner, et al.
ACS Medicinal Chemistry Letters|July 16, 2021
Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 InhibitorsYunsong Tong, Alan S Florjancic, Rick F Clark, et al.
Archives of Pathology & Laboratory Medicine|December 2, 2023
Recommendations for Performance Evaluation of Machine Learning in Pathology: A Concept Paper From the College of American PathologistsMatthew G Hanna, Niels H Olson, Mark Zarella, et al.
Bioorganic & Medicinal Chemistry Letters|January 20, 2007
An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonistsRajesh R Iyengar, John K Lynch, Mathew M Mulhern, et al.
Bioorganic & Medicinal Chemistry Letters|August 9, 2005
Identification of ortho-amino benzamides and nicotinamides as MCHr1 antagonistsAnil Vasudevan, Matthew J LaMarche, Christopher Blackburn, et al.
Pageof 25